As we move ahead, MonoSol Rx remains well positioned to build upon the solid foundation we have established through our proprietary PharmFilm® technology. We now aim for new levels of growth and success through the advancement of our internally-developed product candidates that address unmet needs in a variety of indications where the use of PharmFilm has the potential to improve patient lives with safer, more efficacious treatment options and better patient adherence. In order to maximize our impact on the market, we are augmenting these in-house development programs with select strategic partnerships that enable us to further benefit from the significant value of our PharmFilm® platform.
We have made tremendous strides over the last several years. Our Company's future has never looked brighter, and I am excited to lead the MonoSol Rx team as we approach a number of key inflection points in 2015 and the years to come.
Keith J. Kendall
CEO, MonoSol Rx